Tag: SARS-CoV-2

1. For critically ill patients hospitalized for COVID-19, P2Y12 inhibitors did not improve organ support-free days or survival to discharge ...

Efficacy and Safety of Rivaroxaban for Postoperative Thromboprophylaxis in Patients After Bariatric Surgery: A Randomized Clinical Trial 1. Rivaroxaban is ...

1. Patients in the high-dose dexamethasone group reported significantly greater mortality within 28 days of treatment. 2. Occurrence of non-COVID-19 ...

1. Oral nirmatrelivir, started within 5 days of SARS0-CoV-2, reduces the risk of hospitalization and death at 30 days for ...

Previous BCG vaccination is associated with less severe clinical progression of COVID-19 1. In this case-control study, previous BCG vaccination ...

Low-Value Prostate-Specific Antigen Screening in Older Males 1. This retrospective cohort study demonstrated that males over the age of 70 ...

1. In this randomized trial, in patients with severe COVID-19 pneumonia and biochemical evidence of hyperinflammation, there was no significant ...

1. In this retrospective cohort study of infants exposed to SARS-CoV-2 in utero, there was a significantly higher risk of ...

1. Past infection with ancestral, alpha, beta, and delta variants of COVID-19 had a protection rate of approximately 78% against ...

1. In children presenting to the emergency department (ED) with a COVID-19 infection, children with the Omicron variant were more ...